Issue Price
₹954
Per Share
GMP
NIL
Grey Market
Est. Listing
₹954
Expected Price
Min. Application
₹28,620
2 lots × 15 shares
Incorporated in 2010, Krsnaa Diagnostics Ltd is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres.The firm has an extensive network of diagnostic centres across India with a key focus on non-metro, and lower tier cities and towns. As of December 31, 2020, it operates 1,801 diagnostic centres that are offering radiology and pathology services across 13 different cities in India. In fiscal 2020, the business has served 5.27 million patients.Competitive StrengthsDifferentiated diagnostic service provider company in India.A comprehensive range of diagnostic services i.e. imaging, pathology, etc.Strong brand equity with quality healthcare services at affordable prices.Extensive market footprint in 13 states across India.Consistent financial performance track record.
Krsnaa Diagnostics Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| TOTAL | 12,741,036 | 100.00% | ₹1,215.49 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 15 | ₹14,310 |
| Retail (Max) | 13 | 195 | ₹186,030 |
| sNII (Min) | 14 | 210 | ₹200,340 |
| bNII (Min) | 70 | 1,050 | ₹1,001,700 |
| Particulars | 31-Mar-21 | 31-Mar-20 | 31-Mar-19 |
|---|---|---|---|
| Revenue from Operations | 661.48 | 271.38 | 214.32 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 184.93 | 111.95 | 58.06 |
| Net Worth | N/A | N/A | N/A |
| Total Assets | 604.53 | 629.98 | 528.99 |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |